Home » Newsletters » BioWorld Science

BioWorld Science

May 29, 2017

View Archived Issues

mGlu4 receptor found as a target for treating maladaptive impulsivity

PhoenixMD reports favorable preclinical data on RSK inhibitor for TNBC

FDA advisory committee recommends approval of Pfizer's epoetin alfa biosimilar

Orexin OX2 receptor agonist as promising new therapeutic approach for narcolepsy-cataplexy symptoms

Hovione begins phase I study of HY-02

Lundbeck patents P2X7 receptor antagonists

Hubei Biological Medicine Industrial Technology Institute and collaborator divulge ALK inhibitors

Jiangsu Hansoh Pharmaceutical Group identifies compounds against HCV

Merck KGaA discovers PARP-1 and TANK1/2 inhibitors

Roche presents equilibrative nucleoside transporter 1 inhibitors

Ciprofloxacin DPI benefit not significant in phase III bronchiectasis trial

FDA grants priority review to axicabtagene ciloleucel BLA

FDA grants approval for expanded use of Zykadia in first-line ALK-positive metastatic NSCLC

FDA issues complete response letter for SUN-101/eFlow

Valerion Therapeutics begins recruitment in phase I/II trial of VAL-1221

ENaC inhibitor AZD-5634 shows reduced potential for side effects in first-in-human study

Targeting KLF5 for the treatment of colorectal cancer

FDA grants orphan designation to liposome irinotecan injection for small cell lung cancer

Model recapitulates features of chronic human empyema

Galderma's resiquimod named U.S. orphan drug for cutaneous T-cell lymphoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...